NVAX hit a swing low to open the week and has celebrated federal actions
related to vaccine development with the current uptrend. Having a bit of a
pullback, I see room for an entry. Other vaccine stocks have ad a good week
notably MRNA. This further supports an entry here as buyers from earlier
in the week take their profits. NVAX has been heavily shorted. It is a short
squeeze candidate. An entry here makes sense to me.
related to vaccine development with the current uptrend. Having a bit of a
pullback, I see room for an entry. Other vaccine stocks have ad a good week
notably MRNA. This further supports an entry here as buyers from earlier
in the week take their profits. NVAX has been heavily shorted. It is a short
squeeze candidate. An entry here makes sense to me.
Trade active:
NVAX got a nice 25% pop on earnings. Call options up 140%. Closing 2/3 of them- watching for a drop / correction.
Trade active:
NVAX holding steady despite down-trending market showing relative strength.